Skip to main content

Table 4 Prevalence of HPV 16/18 in both vaccinated (n = 223) and non-vaccinated women (n = 512) by age group, Germany 2010-2012

From: Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling

Age group

n

n vaccinated (%)

HPV 16/18 prevalence

in non-vaccinated women % (95% CI)

HPV 16/18 prevalence in vaccinated women % (95% CI)

p

Mean age [years] at vaccination among vaccinated (n = 188)

Mean time delay [years] between first intercourse and first dose of vaccination (n = 173)

All age groups

735

223 (30.3)

22.5 (18.9-26.3)

13.9 (9.6-13.1)

0.007

17.7

1.3

20-21

213

137 (64.3)

22.4 (13.6-33.4)

10.2 (5.7-16.6)

0.016

16.7

0.5

22-23

288

59 (20.5)

22.7 (17.4-28.7)

20.3 (11.0-32.8)

0.70

18.2

1.6

24-25

234

27 (11.5)

22.2 (16.7-28.5)

18.5 (6.3-38.1)

0.66

20.8

4.3

  1. 95% CI, 95% confidence interval.